Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00383539
What this trial is testing

Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 2,256
Post-approval studies (Phase 4)UnknownNCT04998344
What this trial is testing

An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh

Who this might be right for
Influenza Viral Infections
University of Bergen 3,800
Testing effectiveness (Phase 2)Study completedNCT01072799
What this trial is testing

Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Who this might be right for
Seasonal Influenza
Novavax 4,560
Early research (Phase 1)Study completedNCT02988739
What this trial is testing

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

Who this might be right for
Influenza in Human
Pantec Biosolutions AG 20
Not applicableUnknownNCT04497311
What this trial is testing

Tomographic Findings in COVID-19 and Influenza

Who this might be right for
SARS-CoV-2Covid19H1N1 Influenza+1 more
Universidad de Guanajuato 100
Early research (Phase 1)Study completedNCT02955030
What this trial is testing

Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers

Who this might be right for
Influenza
Nitto Denko Corporation 90
Testing effectiveness (Phase 2)Study completedNCT00992836
What this trial is testing

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

Who this might be right for
HIV InfectionsH1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 155
Not applicableStudy completedNCT06840236
What this trial is testing

Digital Health Intervention On Awareness Of Vaccination Against Influenza Among Adults With Diabetes

Who this might be right for
Diabetes Mellitus Self Management EducationDiabetes
LabStyle Innovations Ltd. 8,431
Large-scale testing (Phase 3)Study completedNCT01788228
What this trial is testing

Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 50
Not applicableStudy completedNCT01046331
What this trial is testing

Novel Influenza A (H1N1) Surveillance Registry

Who this might be right for
Novel Influenza AH1N1Influenza
National Heart, Lung, and Blood Institute (NHLBI) 894
Testing effectiveness (Phase 2)Study completedNCT00959465
What this trial is testing

A/H1N1 Immunogenicity and Safety in Adults

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 408
Testing effectiveness (Phase 2)Study completedNCT03497845
What this trial is testing

Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59

Who this might be right for
Influenza A Virus, H5N1 Subtype
Biomedical Advanced Research and Development Authority 720
Not applicableStudy completedNCT05557539
What this trial is testing

Hypothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach

Who this might be right for
SARS-CoV-2 InfectionInfluenza Viral Infections
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 249
Not applicableStudy completedNCT03392207
What this trial is testing

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

Who this might be right for
Influenza, HumanOrthomyxoviridae InfectionsRNA Virus Infections+4 more
Butantan Institute 403
Not applicableStudy completedNCT02663102
What this trial is testing

Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,388
Testing effectiveness (Phase 2)Study completedNCT00867139
What this trial is testing

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Who this might be right for
Influenza
Fred Hutchinson Cancer Center 7
Not applicableUnknownNCT03399357
What this trial is testing

Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial

Who this might be right for
Influenza VaccineImmune ResponseElderly+3 more
Tan Tock Seng Hospital 240
Post-approval studies (Phase 4)Study completedNCT01430819
What this trial is testing

Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 300
Not applicableStudy completedNCT02154061
What this trial is testing

Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics

Who this might be right for
Influenza
Emory University 33
Post-approval studies (Phase 4)UnknownNCT06208683
What this trial is testing

The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students

Who this might be right for
MumpsInfluenza
Sinovac Biotech Co., Ltd 400
Next Page